Dimensional Fund Advisors
KYTX icon

Dimensional Fund Advisors’s Kyverna Therapeutics KYTX Stock Holding History

Dimensional Fund Advisors’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.89M Buy
278,566
+200,147
+255% +$1.58M ﹤0.01% 2724
2026
Q2 		$699K Hold
78,419
– – ﹤0.01% 2920
2026
Q1 		$677K Buy
78,419
+6
+0% +$50 ﹤0.01% 2910
2025
Q4 		$737K Buy
+78,413
New +$582K ﹤0.01% 2907

Other funds holding KYTX

Gilead Sciences
Gilead Sciences Foster City, California $1.46B AUM 71.23% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
ACPLP
ACT Capital Partners, L.P. Wayne, Pennsylvania $154M AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Dimensional Fund Advisors's KYTX Position: Q3 2026 in Review

Dimensional Fund Advisors increased its Kyverna Therapeutics (KYTX) stake by 255% in Q3 2026, buying an estimated $1.58M and bringing the position to 278,566 shares worth $1.89M. The position accounts for ﹤0.01% of the portfolio, ranked #2724.

Dimensional Fund Advisors first reported a position in KYTX in Q4 2025 and has held it in 4 quarters since. 41 funds tracked by Wall St. Rank hold KYTX as of Q3 2026.

  • Dimensional Fund Advisors held 278,566 shares of Kyverna Therapeutics worth $1.89M as of Q3 2026.
  • Dimensional Fund Advisors bought 200,147 Kyverna Therapeutics shares in Q3 2026, an estimated $1.58M.
  • Kyverna Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2724 holding.
  • Dimensional Fund Advisors first reported a position in Kyverna Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • 41 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.